1. Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction 
Antonio La Marca, Giovanni D’Ippolito 
Reproductive BioMedicine Online 
Volume 28, Issue 2, Pages (February 2014)
DOI: /j.rbmo
Copyright © 2013 Reproductive Healthcare Ltd. Terms and Conditions

2. Figure 1
Relationship between number of oocytes and potential predictors of ovarian response in women after treatment with recommended dose of corifollitropin alpha (from Ledger et al., 2010). (a) According to data from the ENGAGE and ENSURE trials, the mean number of oocytes retrieved was not dependent on drug exposure for women treated with the correct dose of 100 or 150 μg corifollitropin alpha based on their bodyweight. (b–d) As expected, the ovarian response depended mainly on predictors of ovarian response such as baseline FSH (b), AFC (c) and age (d). AUC=area under the receiver operating characteristic curve.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2013 Reproductive Healthcare Ltd. Terms and Conditions

3. Figure 2
OHSS in patients treated with corifollitropin alpha or recFSH. Data from the ENGAGE and ENSURE trials (pooled) (from Tarlatzis et al., 2012).
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2013 Reproductive Healthcare Ltd. Terms and Conditions

4. Figure 3
The normogram of antral follicle count (AFC) in healthy eumenorrhoeic women. Using AFC >20 to exclude potential hyperresponder women from a treatment would result in the exclusion of a very low percentage of women (modified from La Marca et al., 2011).
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2013 Reproductive Healthcare Ltd. Terms and Conditions

5. Figure 4
The relationship between functional ovarian reserve as measured by anti-Müllerian hormone (AMH) or antral follicle count (AFC) and the risk of ovarian hyperstimulation syndrome (OHSS). The linear relationship existing between AMH or AFC and ovarian response in IVF permits to predict increasing risk of OHSS for women with high AMH or AFC. Consequently maximal ovarian stimulation, however obtained, with either long or daily gondotrophins, should be avoided.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2013 Reproductive Healthcare Ltd. Terms and Conditions